Abstract
Molecular biologists have elucidated general principles about chromosomal translocations by cloning oncogenes or fusion genes at chromosomal translocation junctions. These genes invariably encode intracellular proteins and in acute cancers, often involve transcription and developmental regulators, which are master regulators of cell fate (e.g. LMO2 which is involved in acute leukaemia). Chromosomal translocations are usually associated with specific cell types. The reason for this close association is under investigation using mouse models. We are trying to emulate the cell-specific consequences of chromosomal translocations in mice using homologous recombination in embryonic stem cells to generate de novo chromosomal translocations or to mimic the consequence of these translocations. In addition, chromosomal translocation genes and their products are important targets for therapy. We have designed new therapeutic strategies which include antigen-specific recruitment of endogenous cellular pathways to affect cellular viability and a novel structured form of antisense to ablate the function of fusion mRNAs. We will evaluate these procedures in the mouse models of chromosomal translocations and the long term aim is to perfect rapid procedures for characterizing patient-specific chromosomal translocations to tailor therapy to individual patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agrawal A, Eastman QM, Schatz DG . 1998 Nature 399: 744–751
Bemark M, Neuberger MS . 2000 Oncogene 19: 3404–3410
Bentley DL, Rabbitts TH . 1981 Cell 24: 613–623
Bernheim A, Berger R, Lenoir G . 1981 Canc. Genet. Cytogenet. 3: 307–315
Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, Rabbitts TH . 1988a EMBO J. 7: 385–394
Boehm T, Buluwela L, Williams D, White L, Rabbitts TH . 1988b EMBO J. 7: 2011–2017
Boehm T, Foroni L, Kaneko Y, Perutz MP, Rabbitts TH . 1991 Proc. Natl. Acad. Sci. USA 88: 4367–4371
Boehm T, Foroni L, Kennedy M, Rabbitts TH . 1990 Oncogene 5: 1103–1105
Cleary ML . 1991 Cell 66: 619–622
Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH . 2000 EMBO Rep. 1: 127–132
Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie ANJ, King G, Rabbitts TH . 1996 Cell 85: 853–861
Croce CM, Shander M, Martinis J, Cicurel L, D'Ancona GG, Dolby TW, Koprowski H . 1979 Proc. Natl. Acad. Sci. USA 76: 3416–3417
Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature 363: 640–644
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . 1982 Proc. Natl. Acad. Sci. USA 79: 7824–7827
de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spur NK, Heisterkamp N, Groffen J, Stephenson JR . 1982 Nature 300: 765–767
Delassus S, Titley I, Enver T . 1999 Blood 94: 1495–1503
Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, Smith AJH, Rabbitts TH . 1999 EMBO J. 18: 3564–3574
Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH . 2000 EMBO J. 19: 843–851
Drynan LF, Hamilton TL, Rabbitts TH . 2001 Oncogene in press
Dube ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi SC, Crist WM, Carroll AJ, Minowada J, Baker JB . 1991 Blood 78: 2996–3003
Fisch P, Boehm T, Lavenir I, Larson T, Arno J, Forster A, Rabbitts TH . 1992 Oncogene 7: 2389–2397
Fischer A, Malissen B . 1998 Science 280: 237–243
Grutz G, Bucher K, Lavenir I, Larson R, Larson T, Rabbitts TH . 1998 EMBO J. 17: 4594–4605
Hanahan D, Folkman J . 1996 Cell 86: 353–364
Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ . 1991 Science 253: 79–82
Hiom K, Melek M, Gellert M . 1998 Cell 99: 463–470
Hobart MJ, Rabbitts TH, Goodfellow PN, Solomon E, Chambers S, Spurr N, Povey S . 1981 Ann. Hum. Genet. 45: 331–335
Jacobson RH, Zhang X-J, DuBose RF, Matthews BW . 1994 Nature 369: 761–766
Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH . 1991 Proc. Natl. Acad. Sci. USA 88: 8900–8904
Klein G . 1981 Nature 294: 313–318
Kovacs G, Szucs S, De Riese W, Baumgartel H . 1987 Int. J. Cancer 40: 171–178
Larson R, Fisch P, Larson T, Lavenir I, Langford T, King G, Rabbitts TH . 1994 Oncogene 9: 3675–3681
Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH . 1996 EMBO J. 15: 1021–1027
Larson RC, Osada H, Larson TA, Lavenir I, Rabbitts TH . 1995 Oncogene 11: 853–862
Lu M, Gong Z, Shen W, Ho AD . 1991 EMBO J. 10: 2905–2910
Ma Q, Alder H, Nelson KK, Chatterjee D, Gu Y, Nakamura T, Canaani E, Croce CM, Siracusa LD, Buchberg AM . 1993 Proc. Natl. Acad. Sci. USA 90: 6350–6354
MacCorkle RA, Freeman KW, Spencer DM . 1998 Proc. Natl. Acad. Sci. USA 95: 3655–3660
Malcolm S, Barton P, Murphy C, Ferguson-Smith MA, Bentley DL, Rabbitts TH . 1982 Proc. Natl. Acad. Sci. USA 79: 4957–4961
Martineau P, Jones P, Winter G . 1998 J. Mol. Biol. 280: 117–127
McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ . 1989 Mol. Cel. Biol. 9: 2124–2132
Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, Bianchini A, Colomobo E, Schiavoni I, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C, Pelicci PG . 2000 Mol. Cell. 5: 811–820
Nature . 2001 Human Genome Issue Nature Publishing Group: London, UK
Rabbitts TH . 1983 Biochem. Soc. Transac. 11: 119–126
Rabbitts TH . 1991 Cell 67: 641–644
Rabbitts TH . 1994 Nature 372: 143–149
Rabbitts TH . 1998 Genes Dev. 12: 2651–2657
Rabbitts TH, Bucher K, Chung G, Grütz GG, Warren AJ, Yamada Y . 1999 Cancer Res. 59: 1794s–1798s
Rabbitts TH, Forster A, Hamlyn PH, Baer R . 1984 Nature 309: 592–597
Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Gen. 4: 175–180
Rabbitts TH, Hamlyn PH, Baer R . 1983 Nature 306: 760–765
Rabbitts TH, Lefranc MP, Stinson MA, Sims JE, Schroder J, Steinmetz M, Spurr NL, Solomon E, Goodfellow PN . 1985 EMBO J. 4: 1461–1465
Royer-Pokora B, Loos U, Ludwig W-D . 1991 Oncogene 6: 1887–1893
Royer-Pokora B, Rogers M, Zhu T-H, Schneider S, Loos U, Bolitz U . 1995 Oncogene 10: 1353–1360
Sale JE, Neuberger MS . 1998 Immunity 9: 859–869
Sanchez-Garcia I, Kaneko Y, Gonzalez-Sarmiento R, Campbell K, White L, Boehm T, Rabbitts TH . 1991 Oncogene 6: 577–582
Sanchez-Garcia I, Rabbitts TH . 1994 Proc. Natl. Acad. Sci. USA 91: 7869–7873
Schmeichel KL, Beckerle MC . 1994 Cell 79: 211–219
Science. 2001 Human genome issue AACR: Washington, USA
Smith AJH, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts PH . 1995 Nature Genet. 9: 376–384
Stocks MR, Rabbitts TH . 2000 EMBO Rep. 11: 59–64
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P . 1982 Proc. Natl. Acad. Sci. USA 79: 7837–7841
Tavladoraki P, Benvenuto E, Trinca S, De Martinis D, Cattaneo A, Galeffi P . 1993 Nature 366: 469–472
Tse E, Chung G, Visintin M, Catlaneo A, Rabbitts TH . 2001 Protocols for isolating antigen-specific intracellular antibody fragments as single chain Fv for use in mammalian cells. In Methods in Molecular Biology and Medicine J Walker and K Turksen. (eds) Totawa: Humana Press in press
Tse E, Rabbitts TH . 2000 Proc. Natl. Acad. Sci. USA 97: 12266–12271
Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH . 1994 Proc. Natl. Acad. Sci. USA 91: 8617–8621
van Deursen J, Fornerod M, van Rees B, Grosveld G . 1995 Proc. Natl. Acad. Sci. USA 92: 7376–7380
Visintin M, Tse E, Axelson H, Rabbitts TH, Cattaneo A . 1999 Proc. Natl. Acad. Sci. USA 96: 11723–11728
Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R . 1994 EMBO J. 13: 4831–4839
Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH . 1997 EMBO J. 16: 3145–3157
Wagner RW, Flanagan WM . 1997 Mol Med Today 3: 31–38
Warren AJ, Colledge WH, Carlton MBL, Evans MJ, Smith AJH, Rabbitts TH . 1994 Cell 78: 45–58
Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR . 1994 Ann. Rev. Imm. 12: 433–455
Yamada Y, Pannell R, Rabbitts TH . 2000 Proc. Natl. Acad. Sci. USA 97: 320–324
Yamada Y, Warren AW, Dobson C, Forster A, Pannell R, Rabbitts TH . 1998 Proc. Natl. Acad. Sci. USA 95: 3890–3895
Acknowledgements
This work was supported by the Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rabbitts, T. Chromosomal translocation master genes, mouse models and experimental therapeutics. Oncogene 20, 5763–5777 (2001). https://doi.org/10.1038/sj.onc.1204597
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204597
Keywords
This article is cited by
-
Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex
Scientific Reports (2014)
-
Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies
BMC Medical Genomics (2010)
-
The role of CALM–AF10 gene fusion in acute leukemia
Leukemia (2008)
-
CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes
Leukemia (2005)
-
Occurrence of leukaemia following gene therapy of X-linked SCID
Nature Reviews Cancer (2003)